Skip to main content

Vaccine and drug ontology in the study of mechanism and effect

VDOS 2014

Edited by: Dr Sivaram Arabandi, Dr. Yongqun He, Dr. Cui Tao

The 2014 "Vaccine and Drug Ontology Studies" (VDOS 2014) international workshop is the 3rd in this series. The first workshop of the series was organized under the title of the "Vaccine and Drug Ontology in the Study of Mechanism and Effect" workshop (VDOSME 2012; on July 21, 2012, at Graz, Austria. VDOSME 2012 was held as part of the third International Conference on Biomedical Ontology (ICBO 2012). The second workshop of the series was named "Vaccine and Drug Ontology Studies 2013 (VDOS 2013)" ( VDOS 2013 was held on July 7, 2013, at Montreal, Qc, Canada, and occurred prior to the general conference of the fourth International Conference on Biomedical Ontology (ICBO 2013). The workshop name was aimed to reflect the expansion in the scope to more than just mechanism and effect. Like VDOSME 2012 and VDOS 2013, VDOS 2014 was a success. The VDOS 2014 thematic issue in the Journal of Biomedical Semantics includes five full-length papers. These papers have the focuses on two main themes: (i) General vaccine/drug-related ontology development and exploration, and (ii) Interaction and network-related ontology studies. More details about the thematic series papers can be found from the VDOS 2014 Editorial paper.

It is noted that all three thematic series of workshops and papers have the common characteristics:

  • Ontology Coverage: Ontologies of vaccines, of drugs, and of studies thereof.
  • Scope of Interest: Ontology representations, evaluations, comparisons, applications in various biological and clinical areas related to vaccines and drugs.

The workshop, follow-up meetings and activities, and thematic series paper publications, provide an international platform for the researchers and scientists in the vaccine and drug communities to demonstrate research progresses, share ideas, address questions, and promote collaborations for better representation and analysis of vaccine and drug-related terminologies and clinical and research data.

Collection published: 29 July 2015

Last updated: 19 August 2015

  1. The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat ...

    Authors: Cui Tao, Yongqun He and Sivaram Arabandi
    Citation: Journal of Biomedical Semantics 2016 7:6
  2. Vaccines are one of the most important public health successes in last century. Besides effectiveness in reducing the morbidity and mortality from many infectious diseases, a successful vaccine program also re...

    Authors: Yuji Zhang, Puqiang Wu, Yi Luo and Cui Tao
    Citation: Journal of Biomedical Semantics 2015 6:33
  3. While the association between a drug and an adverse event (ADE) is generally detected at the level of individual drugs, ADEs are often discussed at the class level, i.e., at the level of pharmacologic classes ...

    Authors: Rainer Winnenburg, Alfred Sorbello and Olivier Bodenreider
    Citation: Journal of Biomedical Semantics 2015 6:18
  4. Electronic Health Records (EHRs) contain a wealth of information useful for studying clinical phenotype-genotype relationships. Severity is important for distinguishing among phenotypes; however other severity...

    Authors: Mary Regina Boland, Nicholas P Tatonetti and George Hripcsak
    Citation: Journal of Biomedical Semantics 2015 6:14
  5. Literature mining of gene-gene interactions has been enhanced by ontology-based name classifications. However, in biomedical literature mining, interaction keywords have not been carefully studied and used bey...

    Authors: Junguk Hur, Arzucan Özgür, Zuoshuang Xiang and Yongqun He
    Citation: Journal of Biomedical Semantics 2015 6:2

Annual Journal Metrics

  • 2022 Citation Impact
    1.9 - 2-year Impact Factor
    2.6 - 5-year Impact Factor
    0.870 - SNIP (Source Normalized Impact per Paper)
    0.697 - SJR (SCImago Journal Rank)

    2023 Speed
    23 days submission to first editorial decision for all manuscripts (Median)
    265 days submission to accept (Median)

    2023 Usage 
    206 Altmetric mentions